WallStSmart
UNH

UnitedHealth Group Incorporated

NYSE: UNH · HEALTHCARE · HEALTHCARE PLANS

$370.48
-0.07% today

Updated 2026-04-30

Market cap
$336.47B
P/E ratio
28.00
P/S ratio
0.75x
EPS (TTM)
$13.23
Dividend yield
2.38%
52W range
$230 – $398
Volume
8.9M
OverviewPrice TargetsFinancialsValuationInsidersEarnings

UnitedHealth Group Incorporated (UNH) Financial Forecast & Price Target 2030

Research-backed projections from analyst consensus, management guidance, and sector analysis.

Price target summary

Current
$370.48
Consensus
$383.31
+3.46%
2030 Target
$7,291.94
+1868.24%
DCF
$639.74
+42.09% MoS
26 analysts:
15 Buy2 Hold2 Sell

Management guidance

UnitedHealth raised FY2026 adjusted EPS guidance to over $18.25 (from prior guidance), signaling strong turnaround momentum. Management indicated medical cost deflation and operational efficiency gains are driving margin expansion. CEO commentary on Q1 2026 earnings call emphasized AI investments and diversified healthcare operations supporting mid-to-high single-digit revenue growth trajectory.

Sources: Management guidance, analyst consensus, sector analysishigh confidence

Revenue & price projection

Actual revenue Projected revenue Base case Bull to bear range
Bull case (2030)
$12,143.99
$550.9B Rev × 20x P/S
Base case (2030)
$7,291.94
$550.9B Rev × 12x P/S
Bear case (2030)
$4,852.05
$550.9B Rev × 8x P/S

Financial forecast — research-backed

Metric2023202420252026 (E)2027 (E)2028 (E)2029 (E)2030 (E)
Revenue$371.6B$400.3B$447.6B$461.4B$483.6B$486.8B$517.2B$550.9B
Revenue growth—7.7%11.8%3.1%4.8%5.9%6.2%6.5%
EPS$25.12$27.03$16.31$18.25$20.35$21.40$23.10$24.95
P/S ratio———0.5x0.5x12.0x12.0x12.0x
Implied price———$248.44$283.94$6,432.43$6,848.32$7,291.94

Catalysts & risks

Growth catalysts
+ AI-driven operational efficiency improvements in medical cost management and prior authorization standardization
+ Continued healthcare utilization recovery post-pandemic normalization and Medicare Advantage market expansion
+ Synergies from diversified healthcare operations (Optum Health, UnitedHealthcare, Optum Insights) driving cross-selling opportunities
Key risks
- Medicare payment rate pressures and regulatory changes (6B Medicare hit flagged for 2026)
- Medical cost inflation acceleration if healthcare utilization exceeds current deflation trends
- Competitive margin compression from other health insurers and consolidation dynamics

Methodology

UnitedHealth Group Incorporated's forward estimates are derived from AI-powered research synthesis combining analyst consensus from 26 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts from industry research. Revenue and EPS projections use analyst consensus where available and conservative extrapolation with growth deceleration for outer years. Price targets are calculated using a tiered Price-to-Sales (P/S) methodology, where the P/S multiple is determined by the projected revenue growth rate.

WallStSmart proprietary research model · Not financial advice · Past performance is not indicative of future results · Last researched: April 26, 2026.